Adrian K. McKemey serves as President of Certara Drug Development Solutions at Certara, Inc., a global leader in biosimulation software, technology, and services for the pharmaceutical, biotechnology, and regulatory industries. With more than 30 years of experience in life sciences, Adrian has built a distinguished career in clinical development, operations, and strategic leadership at top-tier contract research organizations. Prior to joining Certara, he was President of ICON Clinical Research Services at ICON plc, where he led global clinical operations, driving revenue growth, operational excellence, and the adoption of innovative technologies to streamline clinical trials across diverse therapeutic areas. Adrian's notable achievements include spearheading large-scale clinical programs at Parexel International, where he advanced to Executive Vice President and Head of Global Development Operations. There, he managed a vast portfolio of services, optimized supply chain logistics, and implemented data-driven strategies that accelerated drug development timelines and reduced costs for major pharmaceutical clients. His leadership has consistently delivered successful outcomes, including the advancement of numerous therapies from Phase I through regulatory approval, earning him recognition for fostering high-performance teams and strategic partnerships. In his current role at Certara, Adrian oversees the Drug Development Solutions division, integrating advanced biosimulation, pharmacometrics, and real-world evidence capabilities to de-risk drug development and enhance decision-making for biopharma partners. Under his guidance, the division has expanded its impact by leveraging AI and cloud-based platforms to support precision medicine initiatives, positioning Certara at the forefront of model-informed drug development.